# Donor Dopamine and Initial Graft Function

> **NCT00115115** · PHASE4 · COMPLETED · sponsor: **Universitätsmedizin Mannheim** · enrollment: 487 (actual)

## Conditions studied

- Kidney Transplantation
- ESRD

## Interventions

- **DRUG:** Dopamine infusion to brain dead organ donors

## Key facts

- **NCT ID:** NCT00115115
- **Lead sponsor:** Universitätsmedizin Mannheim
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** 2007-12
- **Final completion:** 2009-03
- **Target enrollment:** 487 (ACTUAL)
- **Last updated:** 2009-04-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00115115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00115115, "Donor Dopamine and Initial Graft Function". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00115115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*